HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Nils Reiss Nikolas Mirow Reiner Körfer Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koyanagi, T. Articles by Körfer, R. Search for Related Content PubMed PubMed Citation Articles by Koyanagi, T. Articles by Körfer, R.

Ann Thorac Surg 1999;67:1350-1354
© 1999 The Society of Thoracic Surgeons

---

Original Articles

Thoracic and cardiovascular interventions after orthotopic heart transplantation

^a Department of Thoracic and Cardiovascular Surgery, Heart Center North Rhine-Westphalia, University of Bochum, Bad Oeynhausen, Germany

Accepted for publication November 19, 1998.

Address reprint requests to Dr Koyanagi, Sakakibara Memorial Hospital, 2-5-4, Yoyogi, Shibuyaku, Tokyo, 151-0053, Japan

Background. The long-term outcome of orthotopic heart transplantation is limited by the development of cardiac allograft vasculopathy, rejection, infection, and malignancy.

Methods. After heart transplantation, we treated patients with thoracic and cardiovascular diseases: preexisting coronary artery sclerosis in 2 patients, cardiac allograft vasculopathy in 19, valvular disease in 3, mycotic ascending aortic aneurysm in 2, superior vena cava stenosis in 2, and lung neoplasm in 10 patients.

Results. We successfully performed coronary artery bypass grafting for preexisting coronary artery sclerosis, valve replacement for valvular disease, and patch enlargement for superior vena cava stenosis. Percutaneous transluminal coronary angioplasty for cardiac allograft vasculopathy achieved excellent initial results, but the incidence of restenosis was high (67%). One patient who underwent coronary artery bypass grafting for cardiac allograft vasculopathy died immediately after operation. Graft replacement was performed for mycotic aortic aneurysm, but 1 patient required reoperation because of recurrent aneurysm. The long-term survival rate in patients undergoing surgical resection for lung neoplasm was poor (50%).

Conclusions. The need for thoracic and cardiovascular interventions in patients after heart transplantation was low (4.7%). Use of the appropriate procedures can improve the long-term survival after heart transplantation.

This article has been cited by other articles:

				K. Ihnken, J. I. Fann, T. A. Burdon, F. L. Johnson, J. C. Kosek, and N. E. Shumway Chronic Mitral Valve Rejection Requiring Replacement in a Nine-Year-Old Allograft Ann. Thorac. Surg., November 1, 2005; 80(5): 1909 - 1911. [Abstract] [Full Text] [PDF]

				S. E. Levy and J. A.S. Muldowney 3rd Microarray Analysis of Neointima: Flowing Toward a Clear Future Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 1946 - 1947. [Full Text] [PDF]

				T. Omoto, K. Minami, T. Muramatsu, S. Kyo, and R. Korfer Pseudoaneurysm after heart transplantation with history of LVAD driveline infection Ann. Thorac. Surg., July 1, 2001; 72(1): 263 - 264. [Abstract] [Full Text] [PDF]